论文部分内容阅读
作者用组织化学方法对肾脏组织的局部纤溶机能进行研究并探讨在肾炎时局部纤溶机能的意义,从肾局部纤溶机能情况考虑纤溶疗法的临床适应症。对象和方法各种肾脏疾病111例,均经肾活组织检查,分为5组,A 组为肾小球肾炎(GN):其中急性肾小球肾炎2例,轻度弥漫增生性肾炎33例,急进性肾炎3例,局灶性肾炎2例,良性发作性血尿9例。B 组为肾病综合征(NS):微小病变型7例,增生型6例,膜型肾病10例,膜性增殖型肾炎6例,局灶型肾小球硬化症(FGS)1例。C 组为系统性疾病;系统性红斑狼疮(SLE)合并 NS 5例,SLE 不伴 NS 8例,糖尿病肾病2例,妊娠中毒症后遗症5例。D 组为血
The authors used histochemical methods to study the local fibrinolysis in renal tissues and to explore the role of local fibrinolysis in nephritis, and to consider the clinical indications of fibrinolytic therapy from the local fibrinolytic function of the kidney. Subjects and Methods 111 cases of various kidney diseases, all by renal biopsy, divided into 5 groups, A group of glomerular nephritis (GN): 2 cases of acute glomerulonephritis, 33 cases of mild diffuse proliferative glomerulonephritis , 3 cases of acute nephritis, 2 cases of focal nephritis, 9 cases of benign serous hematuria. Group B was nephrotic syndrome (NS): 7 cases of minimal change, 6 cases of hyperplastic, 10 cases of membranous nephropathy, 6 cases of membranous proliferative nephritis and 1 case of focal glomerulosclerosis (FGS). Group C was a systemic disease; systemic lupus erythematosus (SLE) with NS 5 cases, SLE without NS 8 cases, diabetic nephropathy in 2 cases and gestation poisoning sequelae in 5 cases. Group D is blood